(see below how to apply)
(start as soon as possible)
(start as soon as possible)
(we are always looking for talented and motivated BSc/MSc students)
(starting in September/October 2023)
CDK12 is transcriptional cyclin-dependent kinase (CDK) found mutated in various cancers. In previous studies we found that CDK12 maintains genome stability via optimal transcription of key homologous recombination repair pathway genes including BRCA1 and plays a role in cell cycle progression by regulating processivity of RNA Polymerase II at core DNA replication genes. Apart from the C-terminal domain of RNA Polymerase II other cellular substrates of CDK12 are not known. In this research we propose using a screen in cells carrying an analog sensitive mutant of CDK12 to discover its novel cellular substrates. The substrates and their roles in normal and cancerous cells will be characterized by advanced techniques of molecular biology and biochemistry.
Background in molecular biology, biochemistry or life sciences. Interest in bioinformatics and data analyses is desirable.
CDK12, transcription, mRNA processing, RNA polymerase II, cancer, genomics, proteomics, substrates, kinase inhibitors
Cyclin-dependent kinase 11 (CDK11) is ubiquitously expressed in all tissues indicating an important role for CDK11 in cells. Our recent studies have shown CDK11 plays key roles in transcription of replication-dependent histone genes and in co-transcriptional mRNA splicing (1, 2). Notably, several recent studies identified CDK11 as a candidate essential gene for growth of several cancers therefore, understanding the molecular mechanism(s) of CDK11-dependent gene expression is also of significant clinical interest. In this research we will use CDK11 inhibitors and advanced techniques of molecular biology and biochemistry to characterize roles of CDK11 in regulation of gene expression and tumorigenesis.
Background in molecular biology, biochemistry or life sciences. Interest in bioinformatics and data analyses is desirable.
CDK11, mRNA splicing, replication-dependent histone genes, SF3B1, cancer, genomics, proteomics, kinase inhibitors, OTS964
Please send your CV and motivational letter explaining your interest to join the lab to Dalibor`s email: dalibor.blazek@ceitec.muni.cz
GACR EXPRO (1/2023-12/2027)
GACR STANDARD (1/2021-12/2023)
TACR TREND (1/2021-12/2024) jointly with Diana Biotechnology and Kamil Paruch, PhD
GAMU (4/2022-12/2024) jointly with Kamil Paruch, PhD